Quantcast

Latest Evaluation methods Stories

2014-08-27 12:34:08

APPLE VALLEY, Minn., Aug. 27, 2014 /PRNewswire/ -- The English Language Proficiency Assessment for the 21(st) Century consortium (ELPA21) has chosen Questar Assessment, Inc. to produce a field test to collect information that will be used to guide the development of its first English Language Proficiency (ELP) Assessment. ELPA21, a consortium of 11 states -- Arkansas, Florida, Iowa, Kansas, Louisiana, Nebraska, Ohio, Oregon, South Carolina, Washington, and West Virginia -- is...

2014-08-26 08:31:43

--Study to Utilize Sequential Parallel Comparison Design to Minimize Placebo Response, Same Design Utilized in AVP-923 Phase II Study in Agitation in Alzheimer's Disease-- ALISO VIEJO, Calif., Aug. 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient into a phase II study to evaluate the efficacy, safety and tolerability of AVP-786 for the adjunctive treatment of major depressive disorder (MDD). AVP-786 is a novel...

2014-08-23 23:01:03

MarketOptimizer.org adds “Cardiomyopathy Global Clinical Trials Review, H2, 2014” to its store. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Dallas, Texas (PRWEB) August 23, 2014 Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and...

2014-08-21 20:22:20

BEIJING, Aug. 21, 2014 /PRNewswire/ -- On August 20(th), Beijing Municipal Commission of Tourism Development and CRI Online jointly launched "Feeling Beijing" Online Contest for Global Audiences in six languages including Chinese, English, German, French, Japanese and Korean, which enables world participants to answer the questionnaire in their native languages by visiting www.cri.cn. The event will last till October 20(th). Questions in the contest cover a wide range of areas,...

2014-08-21 08:29:20

PHILADELPHIA, Aug. 21, 2014 /PRNewswire/ -- ACI Clinical (www.aciclinical.com) announces a new, standards-based platform for independent Data Monitoring Committees. http://photos.prnewswire.com/prnvar/20131120/PH19940LOGO Using this solution, trial sponsors can save up to 30 percent over industry standard costs and receive the same expertise that has made ACI an industry leader in committee services. Leveraging a decade of DMC experience (initial design, member recruitment and...

2014-08-08 08:26:15

LYNBROOK, N.Y., Aug. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX(®) in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma. The Company expects to complete patient enrollment in this trial...

2014-07-29 08:32:50

PLANTATION, Fla., July 29, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) announced today that it has initiated a Phase 2a clinical trial to evaluate bryostatin for the treatment of patients with Alzheimer's disease (AD). Bryostatin is a potent modulator of the enzyme protein kinase C epsilon (PKCe). In preclinical in vivo models, this effect has been shown to play an important role in slowing or reversing AD and restoring cognition, memory and motor skills. The top-line analysis...

2014-07-28 16:25:13

cut-e the leader in online testing and assessment has been sharing its latest research and thinking at applied psychology and testing conferences throughout July. HAMBURG, Germany, July 28, 2014 /PRNewswire-iReach/ -- Dr Achim Preuss, founder and MD of the cut-e Group comments: "As a company, we have witnessed a surge in interest in the value and benefits of online assessment. cut-e is recognised as one of the leaders in online testing because of our commitment and constant drive to...

2014-07-16 12:28:25

Cognitive function is primary endpoint COPENHAGEN, Denmark, July 16, 2014 /PRNewswire/ -- Bracket is pleased to announce that Biotie Therapies, a specialized drug development company focusing on products for neurodegenerative and psychiatric disorders, has selected the CDR System for use as the primary endpoint for their phase 2 trial of SYN120, an orally administered, dual 5HT6/5HT2a antagonist. SYN120 is in development for the treatment of Parkinson's disease and other cognitive...

2014-07-15 23:14:30

Avail is conducting a Phase 2, randomized, placebo-controlled clinical research study to evaluate the efficacy, safety and pharmacokinetics of an experimental spray treatment for qualified participants with mild to moderate osteoarthritis (OA) of the knee. DeLand, FL (PRWEB) July 15, 2014 *To see if you qualify for this Osteoarthritis Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related